Form 4: Humana CEO James A. Rechtin Reports Stock Transactions
SEC Form 4 Filing
Humana's President and CEO, James A. Rechtin, reports the vesting of restricted stock units and associated tax liability payment.
Summary
- On January 8, 2025, James A. Rechtin, President & CEO of Humana Inc., reported transactions involving Humana common stock.
- These transactions include the vesting of 2,182 restricted stock units and the disposal of 978 shares to cover tax liabilities.
- Following these transactions, Rechtin directly owns 4,907 shares and indirectly owns 5,885 shares through revocable trusts.
- Rechtin also holds options to purchase 29,230 shares at $458.185 and 15,772 shares at $367.21.
- The restricted stock units were granted on January 8, 2024, and vest in three annual increments.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment. It's a factual report of insider activity.
Future Outlook
The document does not contain specific forward-looking statements, but it outlines the vesting schedule for restricted stock units and options, indicating future potential stock ownership changes.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their stock transactions. It's common for executives to receive stock options and restricted stock units as part of their compensation packages, aligning their interests with those of shareholders.
Comparison to Industry Standards
- Executive compensation packages often include a mix of salary, bonus, stock options, and restricted stock units.
- The vesting schedules and exercise prices of stock options are generally aligned with industry practices to incentivize long-term performance.
- Companies like UnitedHealth Group (UNH) and CVS Health (CVS) also utilize similar compensation structures for their executives.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely negligible.
- The vesting of restricted stock units is part of the executive's compensation package, impacting their personal financial situation.
Key Dates
| Date | Description |
|---|---|
| 01/08/2024 | Grant date of restricted stock units and options. |
| 01/08/2025 | Date of transaction: vesting of restricted stock units and disposal of shares for tax liability. |
| 01/08/2025 | First vesting date (33%) of restricted stock units granted on 1/8/2024. |
| 01/08/2025 | First vesting date of options granted on 1/8/2024. |
| 01/10/2025 | Date of Form 4 filing. |
| 02/21/2025 | First vesting date of options granted on 2/21/2024. |
| 01/08/2026 | Second vesting date (33%) of restricted stock units granted on 1/8/2024. |
| 02/21/2026 | Second vesting date of options granted on 2/21/2024. |
| 01/08/2027 | Third vesting date (34%) of restricted stock units granted on 1/8/2024. |
| 02/21/2027 | Third vesting date of options granted on 2/21/2024. |
| 01/08/2031 | Expiration date of options granted on 1/8/2024. |
| 02/21/2031 | Expiration date of options granted on 2/21/2024. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.